Cefuroxime and Lamisil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefuroxime (cefuroxime sodium) and Lamisil (terbinafine hydrochloride). Common drug interactions include coagulation factor decreased among females.
The phase IV clinical study analyzes what interactions people have when they take Cefuroxime and Lamisil. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Cefuroxime?
Cefuroxime has active ingredients of cefuroxime sodium. It is often used in sinusitis. eHealthMe is studying from 12,999 Cefuroxime users. Check the latest studies of Cefuroxime.
What is Lamisil?
Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.
14 people who take Cefuroxime and Lamisil together, and have interactions are studied.

What are the common drug interactions of Cefuroxime and Lamisil, by gender? *:
female:
- Coagulation factor decreased (less clotting substance in blood)
- Thrombocytopenia (decrease of platelets in blood)
- Rash
- Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Alanine aminotransferase increased
- Alpha 1 globulin increased
- Alpha 2 globulin increased
- Anisocytosis (patient's red blood cells are of unequal size)
male:
n/a
What are the common drug interactions of Cefuroxime and Lamisil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Alanine aminotransferase increased
- Alpha 1 globulin increased
- Alpha 2 globulin increased
- Anisocytosis (patient's red blood cells are of unequal size)
- Aspartate aminotransferase increased
- Blood albumin decreased
- Blood immunoglobulin g increased
- Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
- Dysphagia (a condition in which swallowing is difficult or painful)
30-39:
n/a
40-49:
- Cellulitis (infection under the skin)
- Chronic kidney disease
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Oxygen saturation decreased
50-59:
- Diabetic retinopathy (damage to the retina caused by complications of diabetes)
- Oedema peripheral (superficial swelling)
- Pulmonary hypertension (increase in blood pressure in the lung artery)
- Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
- Type 2 diabetes mellitus
- Blood pressure increased
- Cardiac failure congestive
60+:
- Coagulation factor decreased (less clotting substance in blood)
- Thrombocytopenia (decrease of platelets in blood)
- Diarrhoea
- Drug hypersensitivity
- Pruritus (severe itching of the skin)
- Rash
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
What are the existing conditions these people have? *
- Skin Ulcer: 3 people, 21.43%
- Osteitis (a general term for inflammation of bone): 3 people, 21.43%
- Sleep Disorder: 2 people, 14.29%
- High Blood Cholesterol: 2 people, 14.29%
- Depression: 2 people, 14.29%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
- Infected Skin Ulcer: 1 person, 7.14%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 7.14%
- Multi-Vitamin Deficiency (lack of vitamins): 1 person, 7.14%
- Renal Disorder (kidney disease): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Cefuroxime and Lamisil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cefuroxime (12,999 reports)
- Lamisil (14,080 reports)
Browse all drug interactions of Cefuroxime and Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefuroxime:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefuroxime and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lamisil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefuroxime sodium and terbinafine hydrochloride (the active ingredients of Cefuroxime and Lamisil, respectively), and Cefuroxime and Lamisil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Celebrex cause Hepatocellular Injury? - 4 seconds ago
- Could Nasacort cause Shock? - 6 seconds ago
- Drug interactions of Amoxicillin and Pentamidine Isethionate - 7 seconds ago
- Paraesthesia and Nausea - 7 seconds ago
- Could Atorvastatin Calcium cause Aphagia? - 10 seconds ago
- Drug interactions of Diflucan and Ezetimibe - 11 seconds ago
- Drug interactions of Dexilant and Rasagiline Mesylate - 17 seconds ago
- Drug interactions of Savella and Hydroxyzine - 17 seconds ago
- Drug interactions of Periactin and Alprazolam - 26 seconds ago
- Drug interactions of Melphalan and Clopra - 32 seconds ago